Title : Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.

Pub. Date : 2016 Oct

PMID : 27663902






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. Fatty Acids ATP citrate lyase Homo sapiens
2 Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. Fatty Acids ATP citrate lyase Homo sapiens
3 Although rodent studies suggested potential effects of ACL inhibition on both fatty acid and cholesterol synthesis, studies in humans show an effect only on cholesterol synthesis. Fatty Acids ATP citrate lyase Homo sapiens